Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Santen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Santen's Japan sales performance.

Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer

Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer The drug is currently approved in more than 70 markets around the world, including the US, EU Japan and China, to treat adults with non-metastatic castration-resistant prostate cancer (nmCRPC)

Amgen acquires ChemoCentryx in $3.7bn cash deal

Amgen acquires ChemoCentryx in $3.7bn cash deal The treatment is also approved in major markets outside the US, including the EU and Japan.

Sarepta to submit application for Duchenne muscular dystrophy gene therapy

Sarepta to submit application for Duchenne muscular dystrophy gene therapy The treatment has also been granted Rare Pediatric Disease (RPD) designation in the US, and Orphan Drug status in the US, the EU, Switzerland and Japan.

Genentech announces positive phase 3 trial results for haemophilia A

Genentech announces positive phase 3 trial results for haemophilia A countries, including the US and Japan for all severities of haemophilia A, and the EU for severe haemophilia A.

Novo Nordisk announces positive phase 3 results for haemophilia treatment

Novo Nordisk announces positive phase 3 results for haemophilia treatment However, Novo Nordisk plans to submit concizumab for regulatory approval for this indication in the second half of 2022 in the US and Japan, and then in 2023 in the EU

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...